Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
Reads0
Chats0
TLDR
Different in vitro, ex vivo and in vivo cell models developed for the testing of these systems with studies involving cell culture analysis are discussed, along with their characterization.Abstract:
Colloidal drug delivery systems have been extensively investigated as drug carriers for the application of different drugs via different routes of administration. Systems, such as solid lipid nanoparticles, polymeric nanoparticles and liposomes, have been investigated for a long time for the treatment of various lung diseases. The pulmonary route, owing to a noninvasive method of drug administration, for both local and systemic delivery of an active pharmaceutical ingredient (API) forms an ideal environment for APIs acting on pulmonary diseases and disorders. Additionally, this route offers many advantages, such as a high surface area with rapid absorption due to high vascularization and circumvention of the first pass effect. Aerosolization or inhalation of colloidal systems is currently being extensively studied and has huge potential for targeted drug delivery in the treatment of various diseases. Furthermore, the surfactant-associated proteins present at the interface enhance the effect of these formulations by decreasing the surface tension and allowing the maximum effect. The most challenging part of developing a colloidal system for nebulization is to maintain the critical physicochemical parameters for successful inhalation. The following review focuses on the current status of different colloidal systems available for the treatment of various lung disorders along with their characterization. Additionally, different in vitro, ex vivo and in vivo cell models developed for the testing of these systems with studies involving cell culture analysis are also discussed.read more
Citations
More filters
Journal ArticleDOI
Diverse Applications of Nanomedicine
Beatriz Pelaz,Christoph Alexiou,Ramon A. Alvarez-Puebla,Frauke Alves,Frauke Alves,Anne M. Andrews,Sumaira Ashraf,Lajos P. Balogh,Laura Ballerini,Alessandra Bestetti,Cornelia Brendel,Susanna Bosi,Mónica Carril,Warren C. W. Chan,Chunying Chen,Xiaodong Chen,Xiaoyuan Chen,Zhen Cheng,Daxiang Cui,Jianzhong Du,Christian Dullin,Alberto Escudero,Alberto Escudero,Neus Feliu,Mingyuan Gao,Michael D. George,Yury Gogotsi,Arnold Grünweller,Zhongwei Gu,Naomi J. Halas,Norbert Hampp,Roland K. Hartmann,Mark C. Hersam,Patrick Hunziker,Ji Jian,Xingyu Jiang,Philipp Jungebluth,Pranav Kadhiresan,Kazunori Kataoka,Ali Khademhosseini,Jindřich Kopeček,Nicholas A. Kotov,Harald F. Krug,Dong Soo Lee,Claus-Michael Lehr,Kam W. Leong,Xing-Jie Liang,Mei Ling Lim,Luis M. Liz-Marzán,Xiaowei Ma,Paolo Macchiarini,Huan Meng,Helmuth Möhwald,Paul Mulvaney,Andre E. Nel,Shuming Nie,Peter Nordlander,Teruo Okano,Jose Oliveira,Tai Hyun Park,Reginald M. Penner,Maurizio Prato,Maurizio Prato,Víctor F. Puntes,Vincent M. Rotello,Amila Samarakoon,Raymond E. Schaak,Youqing Shen,Sebastian Sjöqvist,Andre G. Skirtach,Andre G. Skirtach,Mahmoud Soliman,Molly M. Stevens,Hsing-Wen Sung,Ben Zhong Tang,Rainer Tietze,Buddhisha Udugama,J. Scott VanEpps,Tanja Weil,Tanja Weil,Paul S. Weiss,Itamar Willner,Yuzhou Wu,Yuzhou Wu,Lily Yang,Zhao Yue,Qian Zhang,Qiang Zhang,Xian-En Zhang,Yuliang Zhao,Xin Zhou,Wolfgang J. Parak +91 more
TL;DR: An overview of recent developments in nanomedicine is provided and the current challenges and upcoming opportunities for the field are highlighted and translation to the clinic is highlighted.
Journal ArticleDOI
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application.
TL;DR: A wide discussion about preparation methods, advantages, disadvantages and applications of LNPs is presented by focusing on SLNs and NLCs, two major types of Lipid-based nanoparticles.
Journal ArticleDOI
Therapeutic efficacy of nanoparticles and routes of administration
Dhrisya Chenthamara,Sadhasivam Subramaniam,Sankar Ganesh Ramakrishnan,Swaminathan Krishnaswamy,Musthafa Mohamed Essa,Feng-Huei Lin,M. Walid Qoronfleh +6 more
TL;DR: The most commonly used nanomaterials, their core properties and how surface functionalization would facilitate competent delivery of drugs or therapeutic molecules are explained to facilitate straightforward perception of nanocarrier design, routes of various nanoparticle administration and the challenges associated with each drug delivery method.
Journal ArticleDOI
Nanoparticle decoration with surfactants: Molecular interactions, assembly, and applications
Hendrik Heinz,Chandrani Pramanik,Ozge Heinz,Yifu Ding,Ratan K. Mishra,Delphine Marchon,Robert J. Flatt,Irina Estrela-Lopis,Jordi Llop,Sergio Moya,Ronald F. Ziolo +10 more
TL;DR: A broad review of surface modifications and applications of surfactants is presented in this article, which includes traditional alkyl modifiers, biological ligands, polymers, and other surface active molecules.
Journal ArticleDOI
Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages.
TL;DR: The aim of this article is to review the advantages and limitations of these delivery systems based on the route of administration and to emphasis the effectiveness of such formulations.
References
More filters
Journal ArticleDOI
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
TL;DR: Relevant issues for the introduction of SLN to the pharmaceutical market, such as status of excipients, toxicity/tolerability aspects and sterilization and long-term stability including industrial large scale production are discussed.
Journal ArticleDOI
Development of Nanoparticles for Antimicrobial Drug Delivery
TL;DR: The current progress and challenges in synthesizing nanoparticle platforms for delivering various antimicrobial drugs are reviewed and the need to unite the shared interest between nanoengineers and microbiologists in developing nanotechnology for the treatment of microbial diseases is called attention.
Journal ArticleDOI
The role of lipids in pulmonary surfactant
TL;DR: The lipid composition of mammalian surfactant and the techniques that have been utilized to study the involvement of these lipids in reducing the surface tension at an air-liquid interface, the main function of pulmonary surfactants are described.
Journal ArticleDOI
Mechanisms of macromolecule absorption by the lungs
TL;DR: Although the pulmonary epithelia seem to be naturally permeable to a variety of peptides and proteins, the mechanisms of absorption are poorly understood and an emerging hypothesis is that for small peptides paracellular transport may dominate, while for larger proteins transcytosis may be more important.
Journal ArticleDOI
Pulmonary surfactant therapy.
TL;DR: In 1959, not long after surfactant had been identified as critical to maintaining lung inflation at low transpulmonary pressures, saline extracts from the lungs of preterm infants with respiratory distress syndrome lacked the low surface tension characteristic of pulmonary Surfactant.
Related Papers (5)
Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications
N. R. Labiris,Myrna Dolovich +1 more